토모큐브
475960KOSDAQ사진장비 및 광학기기 제조업49.0 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
Tomocube develops advanced cell imaging equipment, such as HT-2H and HT-X1, based on Holotomography (HT) technology, revolutionizing biomedical research and diagnostics. Widely adopted by over 200 institutions across 50+ countries, including MIT and ETH Zurich, the company is expanding into industrial applications, enhancing growth potential through semiconductor and display measurement devices.
Number of Employees
76people
Average Salary
55.2M KRW
Score Calculation Basis
Detailed Financial Score
6.0x industry avg (risky)
In line with industry avg
Half of industry avg (excellent)
Avg ▲90.4% (1-year basis)
Avg ▲36.6% (1-year basis)
Avg ROE -19.9% (improving, 2yr)
Detailed News Sentiment
- Neutral상장 후 희비 엇갈린 아이빔테크놀로지·토모큐브...왜?
두 기업의 상장 이후 성과가 상반되어 시장에서 주목받고 있지만, 특정 종목인 토모큐브에 대한 직접적인 영향은 명시되지 않았습니다.
- Neutral
Detailed Momentum
52w lower range (34%)
1m -33.80% (strong drop)
Volume decreasing
Detailed Disclosure
- Neutral주식등의대량보유상황보고서(일반)2026-05-28
- Neutral기업설명회(IR)개최2026-05-15
- Neutral분기보고서 (2026.03)2026-05-14
